ArticleProceedings of the National Academy of Sciences of the United States of America2023

Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer.

Thirumagal Thiyagarajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.